Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00058058 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
A NA study of Breast Cancer and Contralateral Breast Cancer, sponsored by American College of Radiology Imaging Network.
- Completed
- Registry status
- NA
- Development phase
- 1,007
- Enrollment target
- 20
- Study locations
NCT00058058 is a NA study of Breast Cancer and Contralateral Breast Cancer that has completed, run by American College of Radiology Imaging Network. The registered enrollment target is 1,007 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (64% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT00058058, a NA study of Breast Cancer and Contralateral Breast Cancer, has completed, sponsored by American College of Radiology Imaging Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,007 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with unilateral breast cancer. PURPOSE: Diagnostic trial to determine the effectiveness of MRI in evaluating the unaffected breast of women recently diagnosed with unilateral breast cancer.
Conditions Studied
Interventions
- PROCEDURE MRI
Study Locations (20)
Pennsylvania
- Abramson Cancer Center at University of Pennsylvania Medical Center - Philadelphia
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia - Philadelphia
- Allegheny General Hospital - Pittsburgh
California
- Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
- UCSF Comprehensive Cancer Center - San Francisco
Florida
- Boca Raton Community Hospital - Boca Raton
- Mayo Clinic - Jacksonville
Illinois
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University - Chicago
- Memorial Medical Center - Springfield
Arkansas
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences - Little Rock
Colorado
- Porter Adventist Hospital - Denver
Connecticut
- Hartford Hospital - Hartford
District of Columbia
- Walter Reed Army Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,007 participants |
| Start Date | 2003-02 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00058058
The ClinicalTrials.gov registry entry for NCT00058058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,007 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (64% lower). The listed sponsor is American College of Radiology Imaging Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT00058058 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Pennsylvania, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00058058 about?
NCT00058058 is a clinical study titled "Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer". RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with unilateral breast cancer. PURPOSE: Diagnostic trial to determine the effectiveness of MRI in evaluating the unaffected breast ...
What is the current status of trial NCT00058058?
This trial is currently completed. It is a NA study. The enrollment target is 1,007 participants. The study started on 2003-02. Estimated completion is 2008-08.
What conditions does trial NCT00058058 study?
This clinical trial studies the following conditions: Breast Cancer, Contralateral Breast Cancer.
What interventions are being tested in trial NCT00058058?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00058058?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00058058 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.